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Gut microbial dysbioses are linked to aberrant im-
mune responses, which are often accompanied by
abnormal production of inflammatory cytokines. As
part of the Human Functional Genomics Project
(HFGP), we investigate how differences in composi-
tion and function of gut microbial communities may
contribute to inter-individual variation in cytokine re-
sponses to microbial stimulations in healthy humans.
Weobservemicrobiome-cytokine interactionpatterns
that are stimulus specific, cytokine specific, and cyto-
kine and stimulus specific. Validation of two pre-
dicted host-microbial interactions reveal that TNFa
and IFNg production are associated with specific
microbial metabolic pathways: palmitoleic acidmeta-
bolism and tryptophan degradation to tryptophol.
Besides providing a resource of predictedmicrobially
derivedmediators that influence immune phenotypes
in response to common microorganisms, these data
can help to define principles for understanding dis-
easesusceptibility. The threeHFGPstudiespresented
in this issue lay the groundwork for further studies
aimed at understanding the interplay between micro-
bial, genetic, and environmental factors in the regula-
tion of the immune response in humans.INTRODUCTION
The gut microbiome is a crucial factor for shaping and modu-
lating immune system responses, with gut microbial dysbioses
linked to several autoimmune and immune-mediated diseases(Gevers et al., 2014; Kosiewicz et al., 2011; Paun et al., 2016).
In the case of rheumatoid arthritis, this dysbiosis can be partially
resolved after treatment (Zhang et al., 2015). While responding to
pathogenic organisms is a main function of the immune system,
recognition and tolerance of commensal bacteria are equally
important for host health (Kosiewicz et al., 2011). Commensal
microbes calibrate innate and adaptive immune responses and
impact the activation threshold for pathogenic stimulations, in
large part by producing small molecules that mediate host-mi-
crobial interactions (Donia and Fischbach, 2015). Short-chain
fatty acids (SCFAs) are a classic example of how bacteria-
derived molecules contribute to gut immune homeostasis (Lee
and Hase, 2014; Thorburn et al., 2014). SCFAs serve as energy
sources for gut epithelial cells, modulate cytokine production,
and induce expansion of regulatory T cells. Consistent with these
functions, SCFAs were implicated in anti-inflammatory proper-
ties of a mix of 17 human-derived Clostridia strains (Atarashi
et al., 2013; Smith et al., 2013). Gut microbial communities
harboring Clostridia are additionally beneficial in that they regu-
late immune function and epithelial permeability to food antigens
to protect against allergen sensitization (Stefka et al., 2014).
Commensal microbiota also modulate systemic immune re-
sponses (Lee and Hase, 2014). While the epithelial barrier en-
sures that microorganisms are largely confined to the gut, micro-
bial metabolites can penetrate the epithelial barrier, allowing
them to enter and accumulate in the host circulatory system
where they are sensed by immune cells (Dorrestein et al.,
2014). For example, dietary tryptophan is metabolized by
different gut bacteria resulting in distinct derivatives, including
indole propionic acid, which is absorbed through the intestinal
epithelium and enters the bloodstream. The biological activity
of indole propionic acid, as is the case for many other small mol-
ecules, is largely unknown (Wikoff et al., 2009).
Given the many examples of commensal microbiota modu-
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Figure 1. Linking Inter-Individual Variation in Immune Response to the Gut Microbiome in the 500FG Cohort
(A) The 500FG cohort comprises 500 healthy adults from the Netherlands. Stool samples were collected and subjected to metagenomic sequencing to infer gut
microbial profiles. Concurrent blood samples were collected to measure the inflammatory cytokine response in connection with various microbial stimulations.
(B) Monocyte- (blue) (IL-6, TNFa, IL-1b) and lymphocyte-derived cytokines (green) (IFNg, IL-17, IL-22) were measured in connection with three bacterial (LPS,
B. fragilis, and S. aureus) and two fungal (C. albicans conidia and hyphae) stimulations in whole blood and/or PBMCs.
(C) Schematic illustrating production kinetics of different cytokines in PBMCs. IL-17 and IL-22 increase steadily during a 7-day period, whereas IL-6 and TNFa
production ismaximal in the first 24 hr and decreases thereafter. IFNg reaches its maximum at 4–5 days, and IL-1b reaches its maximum level at 24 hr, after which
a plateau is attained. Adapted from Ruschen et al. (1992) and van de Veerdonk et al. (2009).
See also Figure S1.between inter-individual variation in gut microbial community
composition and the inflammatory cytokine response to micro-
bial stimulation in healthy individuals (Figure 1). To this end, we
assessed potential functional relationships in multi-omic data
including microbial and cytokine profiles from500 healthy indi-
viduals of Western-European genetic background in the 500
Functional Genomics (500FG) cohort from the Human Functional
Genomics Project (HFGP) (Figure 1A; for exact sample numbers
see Figures S1A and S1B). Several types of microbiome-cyto-
kine interaction patterns were detected. We identified specific
bacterial species and genera that are predicted to influence cyto-
kine production capacity and found putative interactions be-
tween microbial metabolism and tumor necrosis factor alpha
(TNFa) and interferon gamma (IFNg), a subset of whichwe exper-
imentally validated. This work is complemented by two accom-
panying studies linking cytokine responses to host genetics
(Li et al., 2016; [this issue of Cell]) and to host and environmental
factors independent of the microbiome (ter Horst et al., 2016;
[this issue ofCell]) yielding a comprehensive picture of the factors
influencing human cytokine responses and host defense.
RESULTS
Study Overview
To identify associations between the gut microbiome and stim-
ulus-induced cytokine responses, we collected stool samples
from 500 healthy individuals to generate microbial taxonomic
and functional profiles. Blood samples were taken concurrently1126 Cell 167, 1125–1136, November 3, 2016from each individual and the cytokine response was measured
ex vivo in peripheral blood mononuclear cells (PBMCs) and
whole blood under five different microbial stimulations. Three
stimulations were bacteria-derived (purified Escherichia coli-
derived lipopolysaccharide [LPS] and Bacteroides fragilis repre-
senting Gram-negative bacteria, and Staphylococcus aureus
representing Gram-positive bacteria) and two were fungal-
derived (Candida albicans hyphae and conidia yeast) (Figures
1B and S1C). Although most stimulations were pathogens, we
also included the common gut commensal organism Bacter-
oides fragilis, as this species can mediate development of the
host immune system and was detected in 41% of all samples
(Mazmanian et al., 2005). Three monocyte-derived cytokines
(IL-1b, TNFa, IL-6) and three lymphocyte-derived cytokines
(IFNg, IL-17, IL-22) were measured at different times to capture
their peak abundance (Figures 1B and 1C). We then used multi-
variate analyses to identify significant associations between
microbial features and specific cytokine responses.
Between-Subject Variation Is Substantial Both in
Cytokine Response to Stimulation and in Microbial
Composition
We first analyzed the inter-individual variation in the inflamma-
tory cytokine response and the gut microbiome composition,
as this forms the basis for the identification of potential interac-
tions between the two components (Figure 2A). The cytokine
response to the stimulations was compared to the unstimulated
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Figure 2. Healthy Individuals Show Significant Inter-Individual Variability in Stimulated Cytokine Responses and in Gut Microbiota
(A) Inter-individual variation in cytokine response. Each color represents a type of stimulation, also indicated on the upper x axis: CA(C),C. albicans conidia; CA(H),
C. albicans hyphae; LPS, E. coli-derived lipopolysaccharide 100 ng; SA, S. aureus; BF,B. fragilis. Cell type is indicated below the x axis (WB, whole blood; PBMC,
peripheral blood mononuclear cells). The y axis specifies the cytokine response. Each cytokine was measured in a non-stimulated control for each cell type
(RPMI). Stars indicate significant differences in variation for each stimulatory response compared to controls, respectively for each cell type (Fligner-Killeen test,
all p < 1e-15). (Note that B. fragilis-induced TNFameasurements were not considered for further analyses due to a small degree of variation across individuals.)
Whole blood measurements are based on 456 individuals. TNFa, IL-1b, and IL-6 measurements in PBMCs (1 day) were available for 401 individuals; IFNg, IL-17,
and IL-22 measurements in PBMCs (7 days) are based on 462 individuals. Rectangles indicate the interquartile range (Q1–Q3).
(B) Taxonomic microbial profiles displaying phylum-level composition. Sample order was determined by the first principal component (PCA with Bray-Curtis
distance).
(C) Functional microbial profiles displaying the abundance of the ten most variable MetaCyc pathways (based on variance). Samples are in the same order
as in (B).
(D) The overall percentage of cytokine variation explained by species composition of the gut microbiome was 0.4%–9.7%. To avoid overestimation due
to species-species correlations, we represented the microbiota through the first 20 principal coordinates (PCoA with Bray-Curtis distance) that explain 50% of
the variance. The cytokine variance explained by these principal coordinates was estimated through permutation ANOVA by summing over the significant
contributions (p < 0.2).
See also Figure S2.
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unstimulated cells exhibited only a small degree of variation in
cytokine levels, a high degree of inter-individual variation was
observed in response to all stimulations. The difference in the de-
gree of variation was significant for all stimulatory conditions
compared to the unstimulated state for each cytokine and cell
type, respectively (Fligner-Killeen test, all p < 1e-15). Generally,
the intensity of the response to a particular stimulation was cyto-
kine-dependent and in some cases also differed between whole
blood and PBMCs. For most cytokines, the strongest response
was induced by C. albicans; IL-6 was the only cytokine to
show a stronger response to LPS stimulation.
In addition to immunological profiles, we used metagenomic
sequencing reads to identify the species-level composition of
the communities and their functional potential in the form of
encoded genes and pathways. As expected, inter-individual
variation in taxonomic composition was high, with even high-
level phylum composition varying greatly across individuals
(Figure 2B) (Human Microbiome Project Consortium, 2012). At
the functional level, we detected many MetaCyc pathways with
comparable levels across samples, with a subset of generally
less abundant pathways varying more substantially between in-
dividuals (Figure 2C). The microbial profiles from the 500FG
cohort are similar to those of LifeLines-DEEP, another healthy
Dutch cohort within the HFGP (Fu et al., 2015; Tigchelaar et al.,
2015; Zhernakova et al., 2016) and appear to represent a single
population (Figure S1D). In contrast, when these data were
compared with the Human Microbiome Project cohort (consist-
ing of 242 healthy adults from the United States) (Human Micro-
biome Project Consortium, 2012), the two Dutch cohorts
had higher levels of Actinobacteria and lower levels of Bacteroi-
detes. However, a high degree of inter-individual variability was
observed within all cohorts.
Cytokine Variation Explained by the Microbiome
For each of the cytokine measurements, we quantified how
much of the overall variation could be attributed to the gut micro-
biota (Figure 2D). To avoid an overestimation of variability due to
species-species correlations, we used the first 20 principal coor-
dinates to represent the species composition, accounting for
50% of the variability in the microbial composition of the sam-
ples; thus, the variation we observed is a conservative estimate.
The largest percentage of variation in the cytokine response was
explained for TNFa in connection with C. albicans hyphae
(9.7%) and conidia (9.0%) stimulation in PBMCs. For other stim-
ulations, the microbiome accounted for <5% of the variation in
the TNFa response, highlighting the stimulus-specific effect of
the predicted microbiome-cytokine interactions. In addition,
we assessed variation due to functional features using MetaCyc
metabolic pathways and gene ontology (GO) categories. A
maximum of 7.7% and 8.6% of the cytokine variation was ex-
plained by metabolic pathways and GO categories, respectively
(Figure S2).
Three Classes of Microbiome-Cytokine Interaction
Patterns
Because we observed significant inter-individual variation in
cytokine responses and gut microbial profiles, we next assessed
whether these factors were correlated. We predicted three types1128 Cell 167, 1125–1136, November 3, 2016of interaction patterns (IP), referred to as IP1 through IP3 (Fig-
ure 3A). The first interaction pattern (IP1) was stimulus-specific.
In this case, gut microbial features were associated with the
response of several cytokines, but only in connection with a
particular type of stimulation. The second interaction pattern
(IP2) describes cytokine-specific associations that were inde-
pendent of the type of stimulation. In other words, a high/low
response of a particular cytokine was connected to the abun-
dance of a specific gut microbial species or function and
observed in connection with several of the tested stimulations.
Lastly, IP3 microbiome-cytokine interaction patterns were cyto-
kine- and stimulus-specific. Here, a gut microbial component
affected only the response of a particular cytokine and only in
connection with a specific stimulation.
Gut Microbial Species and Genera Are Significantly
Associated with Inflammatory Cytokine Responses
Weperformed pairwise correlation tests betweenmicrobial taxo-
nomic composition at the species and genus levels with each
cytokine in connectionwith a specific stimulation (Spearman cor-
relation with Benjamini-Hochberg FDR correction a % 0.2, Fig-
ures 3B and 3C). A total of 41 species and 20 genera were signif-
icantly associated with at least one potential interaction and
associations were identified for all of the tested cytokines. All
three interaction patternswere observed (Figure 3A) with thema-
jority of associations being cytokine- and stimulus-specific (IP3).
Three stimulus-specific (IP1) associations were observed, with
C. albicans hyphae stimulation in connection with Bacteroides
xylanisolvens, Parabacteroides distasonis, and Coprococcus
comes. Furthermore, three potential cytokine-specific interac-
tions (IP2) were identified. Odoribacter splanchnicus (Figure 3B)
and the genus Bilophila (Figure 3C) were negatively correlated
with TNFa production for LPS and C. albicans stimulations.
Barnesiella was negatively associated with LPS and B. fragilis-
induced IFNg production (Figure 3C). Below, we detail the asso-
ciations encountered for each of the stimulation types.
Taxonomic Associations with Fungal-Induced Cytokine
Responses
Taxonomic features associated with fungal-induced cytokine re-
sponses were often connected to an altered IFNg response (Fig-
ures 3B and 3C). This included common gut commensals such
as Dorea longicatena and Dorea formicigenerans, where higher
species abundances were connected to higher IFNg levels in
response toC. albicans hyphae. BothDorea species canmetabo-
lize sialic acids,whicharecommonly foundat terminal endsofmu-
cins; release of these acids is implicated in mucin degradation,
potentially increasing gut permeability (Crost et al., 2013). In
contrast, another unclassified Dorea species was negatively
correlated with the IFNg response. Thus, different species of
the same genus may affect the IFNg response in opposite
ways. We also observed different species from the same genus
affecting different cytokines. For example, Streptococcus para-
sanguinis and Streptococcus australis were associated with
IFNg production, but other species such as the Streptococcus
mitis/oralis/pneumoniae group were associated with IL-1b.
Examplesofmicrobial organismspredicted toaffectmultiplecyto-
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Figure 3. Significant Correlations between Gut Microbial Abundances and Cytokine Responses to Stimulations
(A) Three microbiome-cytokine interaction patterns were observed. Each colored cell represents a significant interaction between a specific microbial feature
(y axis) and a stimulus-induced cytokine response (x axis). Interaction pattern 1 (IP1) refers to stimulus-specific interactions, where the same microbial feature is
associated with several cytokines in connection with the same stimulation. IP2 describes cytokine-specific interactions, regardless of stimulation. IP3 refers to
interactions that are cytokine- as well as stimulation-specific.
(B and C) Summary of species (B) and genus (C) associations with cytokine responses using Spearman correlation with Benjamini-Hochberg FDR correction
(a% 0.2). All species/genera were required to be detected inR3% of all samples (corresponding toR14 samples). Only species/genera significantly associated
with at least one cytokine response are displayed. CA(C), C. albicans conidia; CA(H), C. albicans hyphae; LPS, lipopolysaccharide 100 ng; BF, B. fragilis; SA,
S. aureus; WB, whole blood; PBMC, peripheral blood mononuclear cells.
(D) A stimulus-specific association ofCoprococcus comeswas observed for IL-1b and IL-6 in connection withC. albicans hyphae stimulation.C. comeswas also
negatively correlated with S. aureus-induced IL-22 production. All displayed cell types are PBMCs.
See also Figure S3 and Tables S1, S2, S3, and S4.associatedwith IFNgproduction (Lo´pez et al., 2011;Me´nardet al.,
2008). Here, we observed a positive correlation between
Bifidobacterium pseudocatenulatum and IFNg. In contrast,
Bifidobacterium adolescentis was inversely correlated with TNFa
production, further emphasizing the potential cytokine- and spe-
cies-specificity of these associations. Further, P. distasonis was
negatively associated with TNFa and IL-1b in response to
C. albicans hyphae stimulation (Figure 3B). In human biopsies,
P. distasonis was significantly more abundant in uninflamed
versus inflamed tissue (Zitomersky et al., 2013). Consistent with
this observation, oral administration of P. distasonis antigens
attenuates intestinal inflammation during colitis in mice (Kverka
et al., 2011).
These associations can also be used to form hypotheses
regarding principles of host-microbial interactions. For instance,
C. comes exhibited stimulus-specific associations with IL-1b
and IL-6 in connection with C. albicans hyphae stimulation, sug-
gesting that C. comes potentially modulates acute phase re-
sponses (Figure 3D). The acute phase response is a non-specificdefense mechanism against microorganisms, characterized by
a cascade involving stimulation of IL-1b and subsequent IL-6
production followed by fever and synthesis of acute-phase pro-
teins. Both cytokines were positively correlated with C. comes,
suggesting immunostimulatory properties of this microorganism
on the acute phase pathway. In an accompanying manuscript
examining host factors that influence cytokine response, ter
Horst et al. (2016) found correlations between IL-1b and the
acute phase protein alpha-1-antitrypsin (AAT). We therefore as-
sessed the impact of C. comes on the circulating concentrations
of AAT and found a positive correlation (r = 0.08, p = 0.08) (Fig-
ure S3) providing further evidence for the connection between
C. comes and acute phase responses. Furthermore, C. comes
demonstrated immunosuppressive properties in connection
with IL-22 production induced by S. aureus (Figure 3D). The
negative correlation of C. comes with IL-22 (in contrast to the
positive correlations observed for IL-1b and IL-6) might at first
appear contradictory, as IL-1b and IL-6 are both required for
Th17 and IL-17/IL-22 production. However, complementaryCell 167, 1125–1136, November 3, 2016 1129
data from the 500FG and 200FG projects show an absence of
correlations between monocyte-derived cytokines (e.g., IL-1b
and IL-6) and T helper cell responses (e.g., IL-22) (Li et al., 2016).
Taxonomic Associations with Bacterial-Induced
Cytokine Responses
Three bacterial stimulations were used: LPS, S. aureus, and
B. fragilis. For TNFa, IL-17, and IL-22, associations were only
observed in connection with a specific bacterial stimulus (Fig-
ures 3B and 3C). A differential IFNg response was observed in
connection with B. fragilis and S. aureus at the species level (Fig-
ure 3B) and LPS and B. fragilis at the genus level (Figure 3C). In
contrast, microbial associations with TNFa were exclusively de-
tected in connection with LPS stimulation, suggesting that the
gut microbiome influences TNFa production in a stimulus-
dependent manner (Figures 3B and 3C; Tables S1, S2, S3, and
S4). In total, three positive and nine negative associations
were found at the species level for LPS-induced TNFa responses
in whole blood and PBMCs. For example, negative associations
between the microbiota and LPS-induced TNFa response
involved multiple diet-sensitive bacteria, including Alistipes
spp., Clostridium spp., and Bilophila spp. (in particular
B. wadsworthia) (David et al., 2014; Devkota et al., 2012). This ef-
fect is particularly interesting given that anti-TNFa therapy is a
common treatment for chronic inflammatory diseases such as
inflammatory bowel disease and rheumatoid arthritis, and these
associations motivate potential microbiome-based therapeutic
approaches.
S. aureus was the only bacterial stimulus where a differential
Th17 response was associated with the microbiota (IL-17 and
IL-22; Figures 3B and 3C). While the IL-17 and IL-22 response
to S. aureus was generally lower compared to fungal-induced
responses, a significant amount of variation was observed for
all stimulations (see Figure 2A). For IL-17, five positive genus
associations were identified, including Clostridium. This genus
includes many species from Clostridium clades IV and XIV,
which enhance T regulatory cell abundance and induce anti-
inflammatory molecules, including IL-17 (Atarashi et al., 2013).
Two negative genus associations with IL-17 production involved
Faecalibacterium andAtopobium (Figure 3C). A prominent mem-
ber of the Faecalibacterium genus, F. prausnitzii, inhibits IL-17
production in rats (Zhang et al., 2014). Our finding suggests
that this may also be true in humans.
In contrast to these stimulus-specific examples, a differential
IFNg response was observed for all bacterial stimulations (Fig-
ures 3B and 3C). For LPS, for example, two negative associa-
tions were detected with Oscillibacter and Barnesiella. Barne-
siella was additionally implicated in the B. fragilis-induced
IFNg response, representing a cytokine-specific interaction
(IP2). One of the species-level associations involving B. fragilis
stimulation was another Bacteroides species, B. nordii. How-
ever, in general the associations observed in connection with
B. fragilis, a commensal gut bacterium, were not unique
compared to the pathogenic stimulations. For example, the
S. aureus-induced IFNg response had three microbial associa-
tions, one being a positive association with Bacteroides cellulo-
silyticus. This observation suggests that while the various
stimulations yield different associations, there does not appear1130 Cell 167, 1125–1136, November 3, 2016to be a unique preferential association of B. fragilis with other
Bacteroides.
Microbial Metabolites Attenuate Pathogen-Induced
TNFa and IFNg Responses
The immune system recognizes and reacts to small molecules
produced by gut microbes, such as the previously mentioned
example of SCFAs. These microbial functional pathways are
often driven by multiple microorganisms, and hence, functional
associations would not necessarily be detected in taxonomic
pairwise association analyses. Therefore, we investigated corre-
lations between cytokine production and MetaCyc metabolic
pathways as well as GO categories, including biological pro-
cesses and molecular functions, to identify functional categories
implicated in differential cytokine responses (Figures 4A and 4B;
Tables S5, S6, S7, and S8).
Functional Associations with Fungal-Induced Cytokine
Responses
Analogous to the taxonomic analysis, we first focused on func-
tional associations in connection with fungal-induced cytokine
responses. The majority of functional associations were de-
tected for the C. albicans conidia-induced TNFa and IFNg
response (Figures 4A and 4B; Tables S5, S6, S7, and S8). For
TNFa, this observation was in contrast to the taxonomic anal-
ysis, where all associations were detected in connection with
LPS stimulation (Figures 3B and 3C). Stimulus-specific interac-
tions patterns involving TNFa and IFNg are not surprising, as
both are regulated by similar transcription factors in T cells,
and IFNg can further induce TNFa expression in dendritic cells.
Furthermore, 10 microbial functional features were predicted
to affect the C. albicans conidia-induced production of TNFa
and IL-22 in the same manner (Figure 4B). Both cytokines are
produced by Th22 cells and can synergistically induce an effec-
tive innate immune response of epithelial cells duringC. albicans
infection, conferring protection in humans (Eyerich et al., 2011).
Our results indicate that there are potential microbial factors
that correlate with the production of both cytokines. In compar-
ison to conidia, very few associations were detected for
C. albicans hyphae, suggesting that the developmental state of
the fungal pathogen is an important factor in determining host-
microbial interactions.
Functional Associations with Bacterial-Induced
Cytokine Responses
Microbial associations with the IL-6 response were detected for
all bacterial stimulations (Figures 4A and 4B). For example, three
MetaCyc pathways (Figure 4A) associated with the LPS-induced
IL-6 response were involved in arginine degradation: cycloserine
biosynthesis (PWY-7274), L-arginine and L-ornithine degra-
dation (ORNARGDEG-PWY), and L-arginine, putrescine, and
4-aminobutanoate degradation (ARGDEG-PWY) (Table S5).
L-arginine depletion mediated by myeloid cell arginase (ARG)
has emerged as a fundamental mechanism of inflammation-
associated immunosuppression (Bronte and Zanovello, 2005).
Our data suggest that the microbiome may play an important
role in arginine depletion and may need to be taken into consid-
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Figure 4. Significant Correlations between Functional Potential of the Gut Microbiome and Cytokine Responses
Functional summary for MetaCyc pathways (A) and Gene Ontology (GO) categories (B) using Spearman correlation with Benjamini-Hochberg FDR correction
(a% 0.2). All functional categories were required to occur inR3% of the samples (R14 samples). CA(C), C. albicans conidia; CA(H), C. albicans hyphae; LPS,
lipopolysaccharide 100 ng; BF, B. fragilis; SA, S. aureus; WB, whole blood; PBMC, peripheral blood mononuclear cells. For MetaCyc pathways and GO cate-
gories, respectively, higher level functional categories are indicated on the left side.
See also Tables S5, S6, S7, and S8.found a connection to the fungal-induced TNFa response,
which was negatively correlated with two of these pathways
(ORNARGDEG-PWY and ARGDEG-PWY).
Immunomodulatory Effects of Tryptophan and
Tryptophol
Most functional associations in connection with bacterial stimu-
lations were detected for IFNg, involving a large number of cyto-
kine-specific interactions (IP2) (Figure 4B). For example, micro-
bial tryptophan degradation to tryptophol (MetaCyc pathway
5081) was negatively associated with IFNg production in whole
blood for S. aureus, LPS, and C. albicans conidia (Figure 5A).
Tryptophan is metabolized in the gut into several molecules
that play an important role in immune regulation, such as limiting
inflammation by interacting with the aryl hydrocarbon receptor(Lamas et al., 2016; Rothhammer et al., 2016), and both trypto-
phan depletion and downstream tryptophan metabolites can
confer protection against excessive inflammation by immune in-
hibition (Opitz et al., 2007). To determine whether this observed
decrease in IFNg levels was due to a decrease in tryptophan or
an increase in the resultingmetabolite tryptophol, we experimen-
tally validated these findings using a whole blood stimulation
assay in healthy human donors. When tryptophan was added
to whole blood, there was no effect on IFNg production induced
by LPS, S. aureus, or C. albicans conidia (Figure 5B). In contrast,
tryptophol significantly decreasedC. albicans- and LPS-induced
production of IFNg. Stimulation with S. aureus also showed a
trend toward decreased IFNg production when tryptophol was
added (Figure 5B). These results show that microbially produced
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Figure 5. Immunomodulatory Effects of Tryptophol and Palmitoleic Acid
(A) L-tryptophan degradation to tryptophol (MetaCyc PWY 5081) was negatively associated with IFNg in connection with S. aureus, LPS, and C. albicans conidia
in whole blood.
(B) Whole blood was stimulated with LPS, C. albicans conidia, or S. aureus in the presence or absence of tryptophan (50 mg/mL) or tryptophol (0.25 mM)
and IFNg concentrations were measured in supernatants for 4 donors. Group differences are expressed as percentage change compared to RPMI
(tryptophan) or ethanol (tryptophol) and analyzed by paired t test. *p < 0.05. Bars indicate the mean percentage change with SEM. Mean values for RPMI
controls in pg/mL: RPMI, 8; LPS, 370; C. albicans conidia, 115; S. aureus, 405. Mean values for ethanol controls in pg/mL: RPMI, 8; LPS, 219; C. albicans
conidia, 131; S. aureus, 91.
(C) Palmitoleic acid biosynthesis (MetaCyc PWY 6282) in PBMCs was positively correlated with C. albicans conidia-induced TNFa production.
(D) Cis-vaccenate biosynthesis (MetaCyc PWY 5973) was positively correlated with IFNg (in whole blood) and TNFa (in PBMCs) in connection with C. albicans
conidia stimulation.
(E) PBMCs from five to six healthy volunteers were stimulated with C. albicans conidia in the presence or absence of palmitoleic acid and cis-vaccenate
(cis-vaccenic acid). Cytokine concentrations were measured in supernatants. Group differences are expressed as percentage change compared to ethanol or
DMSO measurements and analyzed by paired t test. ***p < 0.001. Bars indicate the mean percentage change with SEM. Mean values in pg/mL: TNFa (DMSO,
10,000; ethanol, 10,000; palmitoleic acid, 1,504; cis-vaccenate, 9,957); IFNg (DMSO, 1,370; ethanol, 1,571; palmitoleic acid, 976; cis-vaccenate, 2,241).
See also Figure S4.
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Palmitoleic Acid Can Inhibit the Pro-inflammatory
Cytokine Response
Two related MetaCyc pathways showed positive correlations
with TNFa in response toC. albicans conidia stimulation: palmito-
leic acid biosynthesis (MetaCyc PWY 6282) and cis-vaccenate
biosynthesis (MetaCyc PWY 5973) (Figures 5C and 5D).
Cis-vaccenate biosynthesis was also positively associated with
IFNgproduction. Palmitoleic acidbiosynthesis hasabranchpoint
from a palmitoleoyl [acp] to the cis-vaccenate pathway (Fig-
ure S4A). Thus, increased activity in the palmitoleic acid biosyn-
thesis pathway could result in either more palmitoleic acid or
more cis-vaccenate if the cis-vaccenate pathway were also
active. In the second scenario, an increase of cis-vaccenate
would utilize the substrate for palmitoleic acid biosynthesis, re-
sulting in less palmitoleic acid production. Given that our associ-
ationswith cis-vaccenatebiosynthesis have a positive correlation
with TNFa and IFNg, it is possible that increased palmitoleic acid
corresponds to decreased cytokine production. We tested how
the presence of these molecules affects C. albicans conidia-
inducedcytokineproduction in humanPBMCs (Figure 5E). Palmi-
toleic acid decreasedTNFa production but had no effect on IFNg.
However, cis-vaccenate (cis-vaccenic acid) did not influence
cytokine production under any of the tested stimulations (Fig-
ure 5E). Interestingly, palmitoleic acid displayed an anti-inflam-
matory effect in connectionwith all of themonocyte-derivedcyto-
kines (IL-1b, TNFa, IL-6), but hadnoeffecton lymphocyte-derived
cytokines (IFNg, IL-17, IL-22) (Figures S4B and S4C).
DISCUSSION
The HFGP is a comprehensive study that aims to identify the
most important factors influencing cytokine production capacity
in healthy humans. In three complementary studies, we report
the environmental, genetic, and microbiome factors associated
with cytokine production induced by different microbial stimula-
tions in a cohort of 500 healthy volunteers. While accompanying
studies demonstrate the impact of environmental and host fac-
tors (genetic and non-genetic) for the modulation of cytokine
production (Li et al., 2016; ter Horst et al., 2016), in this study
we provide evidence that the gut microbiome also has biologi-
cally relevant effects.
Our analysis indicates that inter-individual variation in cytokine
response is linked to specific microbial organisms as well as mi-
crobial functions. The majority of detected associations were
both cytokine- and stimulus-specific (IP3), suggesting that the im-
mune system recognizes and interacts with microbial organisms
and productswith high specificity and that thesemicrobial factors
are associated with a particular immunological phenotype.
In particular, a broad range of microbial functional features was
associated with cytokine responses. This observation suggests
thatmodulation of host defense by themicrobiotamay be exerted
mainly through the release of intermediary common mediators
(such as metabolites) rather than direct interaction between spe-
cific microorganisms and immune cells. This finding constitutes
the first important conclusion that can be drawn from our data.
An important role for metabolites in microbiome-cytokine inter-
actions is supported by the fact that a large proportion of the me-
tabolites in the blood originate from the gut (Sridharan et al., 2014;Wikoff et al., 2009), as well as our findings of the strong impact of
microbial metabolic processes on cytokine production (Figure 4).
Among these metabolic processes, we experimentally validated
the important impact of microbial tryptophan metabolism, a
pathway known to modulate cytokine production at the level of
host metabolism (Moffett and Namboodiri, 2003; Nowak et al.,
2012). Here, we demonstrate that microbial tryptophan meta-
bolism strongly influences cytokine production. Interestingly,
this effect ismainlymediated by the tryptophanmetabolite trypto-
phol, which has strong inhibitory effects on the TNFa response.
However, the inhibitory effect depends on the particular patho-
genic stimulation. We also validated a predicted interaction
involving palmitoleic acid metabolism. Palmitoleic acid inhibits
apoptosis induced by a combination of IL-1b and IFNg (Welters
et al., 2004), but a specific effect on IFNg synthesis has not been
previously reported. Interestingly, we not only validated this rela-
tionship in human cell stimulation assays, but also demonstrated
a specific effect of palmitoleic acid on monocyte-derived cyto-
kines (TNFa, IL-1b, IL-6) but not lymphocyte-derived cytokines
(IFNg, IL-17, IL-22). The molecular mechanisms responsible for
this specificity remain tobeelucidated in future studies. These val-
idations serve asproof-of-principle of howpredicted associations
can be used to provide insight into host-microbial interactions.
In addition to the observations concerning modulation of cyto-
kineproductioncapacitybymicrobial functions,wealsopredicted
interactionsof specificmicrobial species andgenera, including the
effect ofC. comes on cytokines of the acute phase pathway (IL-1b
and IL-6). The production of IL-1b and IL-6 is regulated largely at a
genetic level (Li et al., 2016) and less influenced by microorgan-
isms. The physiological relevance of this finding is supported by
our subsequent analysis showing that C. comes is associated
with circulating concentrations of the acute phase protein AAT.
This connection was observed despite the fact that AAT was
measured during health, not after microbial challenge or infection.
Insight into gutmicrobiota and immune system interactions is a
crucial step in understanding immune-mediated and infectious
diseases. For example, differential abundance of specific gut
bacteria was associated with cytokine responses and may
impact disease susceptibility. This effect was exerted directly
on the intrinsic cytokine production capacity of the immune cells,
rather than by influencing the number of cells in circulation: no
effect of microbiota composition on the most important immune
cell populations (T/B lymphocytes, monocytes, neutrophils, NK
cells) was detected in the present study (data not shown).
Evaluating the results of the three studies presented in this
issue, it appears that variation at many levels affects the inflam-
matory response. An earlier study showed that host genetic var-
iants modulate pathogen sensing in dendritic cells stimulated
with microbial ligands (Lee et al., 2014), and we now present a
muchbroader assessment of the genetic (Li et al., 2016) andenvi-
ronmental factors (ter Horst et al., 2016) that modulate cytokine
production. Non-genetic factors such as age, gender, and sea-
son have a strong influence on cytokine production capacity,
and genome-wide analyses have identified 17 independent loci
that influence cytokine production at a genome-wide level.
Here, we demonstrate that the microbiome also plays a key
role in the regulation of cytokine production. This conclusion is



































Study 3: Gut Microbiome
1.  Microbiome functions are 
more influential than 
taxonomic features
2. Strongest effects on IFNγ 
and TNFα production
1. 17 independent loci
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cytokine response
Figure 6. Environmental, Host Genetic, and
Gut Microbial Factors Impact Human Cyto-
kine Responses
The impact of host environmental factors (ter
Horst et al., 2016), host genetics (Li et al., 2016),
and the gut microbiome (this study) on stimulus-
induced cytokine responses was assessed in
three complementary studies of the HFGP. While
gender and seasonality were the main environ-
mental factors affecting the response of mono-
cyte-derived cytokines, age was associated with
IL-22 and IFNg production. Further, 17 indepen-
dent loci were implicated in specific differential
cytokine responses of monocyte- and Th-derived
cytokines. Lastly, gut microbial functions were
more influential on cytokine production than
taxonomic features, where the strongest effects
were observed for the stimulus-induced IFNg and
TNFa responses.antibiotic treatment greatly impact development of autoimmune
diseases suchaspsoriasis (Zanvit et al., 2015) andareassociated
with allergic asthma susceptibility (Russell et al., 2012). In addi-
tion, the use of antibiotics is associated with a more pronounced
dysbiosis in children with Crohn’s disease, implicating perturba-
tions of the gut microbiota in disease (Gevers et al., 2014).
The HFGP provides the opportunity to evaluate the impor-
tance of these host-dependent factors. Although host genetic
variability and microbiome composition both influence cytokine
production, our analyses suggest a greater impact of host ge-
netics, explaining 25%–50% of the variability of some cytokine
responses, compared to the microbiome, explaining only up to
10% of cytokine variability.
Several limiting factors can introduce noise to the microbiome
data, resulting in smaller correlation coefficients. First, any
experimentally obtained data contain noise; for example, the im-
mune cells were stimulated ex vivo, outside the environment
where the cells were exposed to microbial factors, potentially
weakening the detectable effects of host-microbial interactions.
Second, simultaneously occurring host-microbial associations
may affect each other adversely. Importantly, the effect size
does not necessarily provide knowledge about biological signif-
icance, as illustrated by the experimental validation of two func-
tional associations, providing conclusive evidence for the spec-
ificity of these host-microbial interactions.
The HFGP studies provide a comprehensive assessment of
the effects of host and environmental factors on cytokine pro-
duction capacity at a population level. Integrated approaches
initiated in HFGP enabled us to identify important general inter-
action characteristics of different biological traits in the human
hosts (Figure 6). First, general characteristics of the host such
as age and gender have an important impact on inflammation.
Men display a higher production of monocyte-derived proinflam-1134 Cell 167, 1125–1136, November 3, 2016matory cytokines, whereas women have
a greater Th17 response (ter Horst
et al., 2016). These differences may pro-
vide a partial explanation for differences
in pathologies betweenmen andwomen:men are more susceptible to metabolic and cardiovascular dis-
eases, whereas women more often have autoimmune diseases
(Regitz-Zagrosek, 2006; Regitz-Zagrosek et al., 2006). In addi-
tion, a defective IFNg production capacity has been observed
in elderly people (Ouyang et al., 2002), which may explain their
increased susceptibility to infections. Second, genomic ap-
proaches in HFGP demonstrate the importance of host genetics
for determining cytokine responses. Although this concept is not
new, here we have analyzed a large healthy population in a
genome-wide fashion and report 17 new genetic loci associated
with specific responses (Li et al., 2016). Third, we found that the
effects of both genetic and microbiome factors are mainly stim-
ulus- and cytokine-specific, and interesting new patterns
emerged: TNFa and IFNg production capacity appear to
be more strongly influenced by the microbiome, whereas other
cytokines such as IL-1b, IL-6, and Th17-derived IL-17 and IL-
22 exhibit fewer, but more specific, associations with the gut
microbiota. This finding is in line with genetic data showing an
opposite trend for monocyte- and Th-derived cytokines (Li
et al., 2016). These findings may have important consequences
for approaches to immunotherapy targeting specific cytokines to
alter immune responses: while inhibition of cytokines that are
strongly influenced by the microbiome can potentially be modu-
lated through diet, elimination of specific species, or fecal micro-
biota transplantation, host genetics-modulated cytokines may
be more effectively targeted through inhibitory pharmacological
approaches (e.g., neutralizing monoclonal antibodies).
Through these three complementary HFGP studies assessing
the impact of the host microbiome (this study), environmental (ter
Horst et al., 2016), and host genetic factors (Li et al., 2016), we
are able to glimpse the complexity of the mechanisms driving
the variability of human cytokine responses. These studies
open the possibility for future similar investigations in patient
groups to identify the variation and disturbances responsible for
their diseases in a personalized fashion, thereby providing the
basis for precision medicine.
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